Literature DB >> 16113565

The Role of RCAS1 and oxytocinase in immune tolerance during pregnancy.

L Wicherek1, M Dutsch-Wicherek, P Mak, M Klimek.   

Abstract

OBJECTIVES: To determine and compare the level of RCAS1 (receptor-binding cancer antigen expressed in SiSo cells) in placentas at term as well as oxytocinase/cystine amino peptidase (CAP) serum level a few days before labor in order to evaluate their possible role in the regulation of maternal immune response during pregnancy and in initiation of labor.
METHODS: We estimated the RCAS1 content in 44 placental tissue samples, using Western blot method. We also assessed CAP serum level by its enzymatic activity, using L-cystine-di-beta-naphthylamide as a synthetic substrate. The statistical analysis was performed using Shapiro-Wilk procedure. Student's t test was applied to compare the differences between parametric data. A value of p < 0.05 was considered significant.
RESULTS: RCAS1 was found in all placental tissue samples examined. The differences in the RCAS1 relative amount depended on the onset of labor, with the highest level in induced labor and the lowest in spontaneous labor. The differences were also observed in the CAP serum level with the highest level in pregnant women whose labor was induced.
CONCLUSIONS: We have observed a link between the expression of the two proteins examined and the onset of the labor. Therefore, we posit that RCAS1 and CAP may play a role in the downregulation of the maternal immune response during pregnancy and may participate in the initiation of the labor. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16113565     DOI: 10.1159/000086824

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  8 in total

Review 1.  Placental leucine aminopeptidase- and aminopeptidase A- deficient mice offer insight concerning the mechanisms underlying preterm labor and preeclampsia.

Authors:  Shigehiko Mizutani; John W Wright; Hiroshi Kobayashi
Journal:  J Biomed Biotechnol       Date:  2010-12-06

2.  The placental RCAS1 expression during stillbirth.

Authors:  Lukasz Wicherek; Marek Klimek; Artur Czekierdowski; Tadeusz J Popiela; Krystyna Galazka; Tomasz Tetlak; Andrzej Gilowski; Magdalena Dutsch-Wicherek
Journal:  Reprod Biol Endocrinol       Date:  2005-06-17       Impact factor: 5.211

3.  Comparison of RCAS1 and metallothionein expression and the presence and activity of immune cells in human ovarian and abdominal wall endometriomas.

Authors:  Lukasz Wicherek; Magdalena Dutsch-Wicherek; Krystyna Galazka; Tomasz Banas; Tadeusz Popiela; Agata Lazar; Beata Kleinrok-Podsiadlo
Journal:  Reprod Biol Endocrinol       Date:  2006-08-14       Impact factor: 5.211

4.  Endometriosis node in gynaecologic scars: a study of 17 patients and the diagnostic considerations in clinical experience in tertiary care center.

Authors:  Rocío Vellido-Cotelo; Jose L Muñoz-González; Maria R Oliver-Pérez; Cristina de la Hera-Lázaro; Cristina Almansa-González; Concepción Pérez-Sagaseta; Jesús S Jiménez-López
Journal:  BMC Womens Health       Date:  2015-02-18       Impact factor: 2.809

5.  The association between RCAS1 expression in laryngeal and pharyngeal cancer and its healthy stroma with cancer relapse.

Authors:  Magdalena Dutsch-Wicherek; Romana Tomaszewska; Agata Lazar; Lukasz Wicherek; Jacek Skladzien
Journal:  BMC Cancer       Date:  2009-01-28       Impact factor: 4.430

6.  Molecular Changes on Maternal-Fetal Interface in Placental Abruption-A Systematic Review.

Authors:  Monika Bączkowska; Magdalena Zgliczyńska; Jan Faryna; Ewa Przytuła; Błażej Nowakowski; Michał Ciebiera
Journal:  Int J Mol Sci       Date:  2021-06-21       Impact factor: 5.923

Review 7.  The possible correlation between the patient's immune tolerance level during cesaerean section and the incidence of subsequent emergency peripartum hysterectomy.

Authors:  Lukasz Wicherek; Krystna Galazka
Journal:  Clin Dev Immunol       Date:  2007

8.  The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration.

Authors:  Magdalena Dutsch-Wicherek; Romana Tomaszewska; Pawel Strek; Lukasz Wicherek; Jacek Skladzien
Journal:  BMC Immunol       Date:  2006-03-21       Impact factor: 3.615

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.